• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Corporation
Lifestyle

SCL Healthcare Draws Attention for Its ADC Analysis Capabilities on InterBiz

SCL Healthcare, a subsidiary of SCL Science(246960), announced on the 3rd that it recently participated in the “24th InterBiz Bio Partnering & Investment Forum 2026” held in Jeju, showcasing its capab…
  • 2026-07-03 09:25:02
  • KIM JI-WAN
SMEs

APR Sweeps No. 1 Spot on Amazon Prime Day in the U.S. and Europe

Global beauty company APR(278470)ranked among the top search terms and best-selling products during the “Amazon Prime Day” event, which took place simultaneously in the U.S. and Europe. The company’s …
  • 2026-07-03 09:00:42
  • KIM EUNG-TAE
Lifestyle

Dop Emerges as the Biggest Beneficiary of the Waste Management Act Amendment... Positive Signs for Reaching 50 Billion Won in Annual Revenue

DOP has emerged as the biggest beneficiary following the passage of a partial amendment to the Waste Management Act, which paves the way for the medical use of human fat. DOP, a company specializing i…
  • 2026-07-03 08:31:02
  • YU JIN-HEE
Lifestyle

NamyangDairyProducts Reduced Greenhouse Gas Emissions by 13% Last Year

NamyangDairyProducts(003920)has reportedly achieved double-digit reductions in both greenhouse gas emissions and energy consumption last year. NamyangDairyProducts announced on the 3rd, through…
  • 2026-07-03 08:30:45
  • SIN SOO-JUNG
Lifestyle

Celltrion Reports Record-High Second-Quarter Revenue of 1.3 Trillion and Operating Profit of 430 Billion

(Photo courtesy of Celltrion) Celltrion(068270)reported its best-ever second-quarter earnings, driven by expanded sales of high-margin biosimilars. With new product sales accounting for over 60% o…
  • 2026-07-03 08:23:02
  • SONG YOUNG-DOO
Lifestyle

[BioUSA] Jeon Young-ho, CEO of EzQuris: “Expectations for a First-in-Class Drug; Background on Joint Research with AZ”

"The idea of developing antibody drugs as small molecules caught AstraZeneca's attention. Our goal is to create treatments that more patients can use while maintaining their efficacy."Jeon Young-ho, C…
  • 2026-07-03 08:11:11
  • SONG YOUNG-DOO
Lifestyle

Mixed Market, Solid Footing: Psomagen and Jetema Stand Out [K-Bio Pulse]

While the domestic stock market has recently remained mixed and struggled to find a clear direction, the pharmaceutical and biotech sectors have carved out an upward trajectory. This rally is backed b…
  • 2026-07-03 08:02:03
  • YU JIN-HEE
Lifestyle

Amid a Mixed Stock Market, Psomagen, Inc. and JETEMA Co.,Ltd. Stand Out [Bio Spotlight]

While the domestic stock market has recently been showing mixed trends without a clear direction, the pharmaceutical and biotech sectors have been on an upward trend, driven by clear prospects for ear…
  • 2026-07-03 08:02:02
  • YU JIN-HEE
Electronics

President Lee: "Thank You for Your Bold Decision"... Lee Jae-yong: "Proactive Investment Drives Growth"

“Samsung’s dream took root, grew, and bore fruit in Chungcheong.” (Lee Jae-yong, Chairman of SamsungElectronics)"Building on our achievements to date, we will develop the Chungcheong region into a glo…
  • 2026-07-02 17:32:11
  • Kong Chi-Yu
Lifestyle

HANSAEMK to Cancel 9.2 Billion Won Worth of Treasury Stock… “Strengthening Shareholder Returns”

HANSAEMK(069640)has decided to cancel its treasury shares, marking a move to expand shareholder returns. Courtesy of HANSAEMK. HANSAEMK announced on the 2nd that it plans to cancel 667,770 commo…
  • 2026-07-02 17:27:32
  • Kim Ji-woo
prev 71 72 73 74 75 76 77 78 79 80 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English